Thirty-six alkyl organophosphorus compounds have been tested for neurotoxicity in the chicken. The individual compounds were chosen to enable the importance of each portion of the molecule to be assessed in relation to the property of neurotoxicity. Seventeen substances were found to be neurotoxic, fifteen for the first time. All of these contained fluorine. On the basis of the results reported, certain predictions have been made about the chemical structure of compounds which would be expected to be neurotoxic. The importance of fluorine suggests that it plays a direct role in the development of the biochemical lesion, and this may occur as the result of its being carried by the molecule as a whole to specific areas in the nervous system. By the action of cholinesterase, the P-F bond may be ruptured and ionic fluorine liberated where it blocks some metabolic cycle.
Ginger paralysis, Jake paralysis, Jamaica ginger polyneuritis or triorthocresyl phosphate poisoning were some of the names given to a condition which afflicted a very large number of people throughout the Southern States of the United States of America during 1930 (Kidd and Langworthy, 1933) . It was caused by the ingestion of an alcoholic extract of Jamaica ginger adulterated with tri-o-cresyl phosphate (Smith, Elvove and Frazier, 1930) .
Since a similar condition has been observed in man after poisoning by NN'-diisopropylphosphorodiamidic fluoride (mipafox) (Bidstrup and Bonnell, 1954) and in chickens following diisopropyl phosphorofluoridate (dyflos), mipafox (Barnes and Denz, 1953 ) and a number of aryl phosphates other than tri-o-cresyl phosphate (Hine, Dunlap, Rice, Coursey, Gross and Anderson, 1956; Henschler, 1958) , the names above are no longer satisfactory for this condition. Because the histological lesions produced by these substances are confined to the nervous system (Smith and Lillie, 1931; Barnes and Denz, 1953; Fenton, 1955; Cavanagh, 1954) it is proposed to refer to this condition as organophosphorus neurotoxicity or, for brevity, neurotoxicity.
Detailed accounts of both the clinical and histological picture have been given by many writers, and the following due to Kidd and Langworthy (1933) is typical of the clinical picture in man after poisoning by tri-o-cresyl phosphate. Following a symptomless period of 5 to 30 days there occurs a tingling numbness or cramping pain in the calves, which lasts for 1 or 2 days. This is followed by a rapid onset of complete or partial paralysis of the extensor muscles of the toes and feet, together with variable degrees of weakness, but always with loss of ankle jerks. A week later the muscles of the hand and forearm develop a sudden weakness and bilateral paralysis involving both sides to an equal extent. The course of the illness is chronic and little improvement can be observed for months after onset. Even when it occurs, progress is slow.
There is considerable variation in both the clinical and histological appearances of the disease in various species (Smith, Elvove and Frazier, 1930) and it is only in the hen and the cat that the appearances closely resemble those seen in man (Smith, Engel and Stohlman, 1932) . Most experimental work has been carried out in chickens where the histological lesions are limited to the ascending and descending fibres of the sciatic nerve, the spinal cord and the cerebellum. The changes consist of myelin and axon degeneration (Cavanagh, 1954; Fenton, 1955) .
Previous to the work to be described in this paper only a limited number of compounds were known to be neurotoxic. These were dyflos, mipafox and certain triaryl phosphates. Consequently it was not possible to recognize any correlation between chemical structure and neurotoxicity. This paper presents the results of a systematic study of the relationship between the structure of certain organophosphorus compounds and neurotoxicity. A number of these compounds have been shown for the first time to be neurotoxic. All of these contain fluorine; in addition the significance of the other groups in the molecule has been worked out.
METHODS

Chemical Methods
Phosphorofluoridates.-The majority of these were prepared by the method of Ford-Moore, Lermit and Stratford (1953) . This was modified for the preparation ethyl propyl phosphorofluoridate (British Intelligence Objectives Subcommittee, 1945) and for di(l-methylbutyl) phosphorofluoridate (Goldwhite and Saunders, 1955) .
Diethyl Phosphorofluaridothionate. -This was prepared from the phosphorochloridothionate, replacing the chlorine atom by a fluorine atom, by the action of antimony trifluoride in the presence of antimony pentachloride.
Alkylphosphonofluoridates.-These were obtained by the action of phosgene on the appropriate alkyl alkylphosphonate to give the alkylphosphonochloridate, and this on treatment with sodium fluoride gave the alkylphosphonofluoridate (Coe, Perry and Brown, 1957) .
Dialkylphosphinic Fluorides.-Treatment of the corresponding chlorides with a mixture of sodium fluoride and sodium bifluoride gave the dialkylphosphinic fluorides.
Dialkylpyrophosphonates.-These were obtained pure by reacting the silver salt of an alkyl hydrogen alkylphosphonate with an alkyl alkylphosphonochloridate (Kosolapoff, 1950) .
Tests of Purity and Identification.-The purity and identity of all the compounds were established by examination of the infra-red spectrum, determination of the refractive index and, in some cases, determination of the carbon and hydrogen. With one exception, which is discussed in the text, all the compounds were at least 95% pure at the time of testing. The chemical structure and physical constants of the 36 compounds examined are shown in Table I .
Biological Methods
Chickens of mixed breed and both sexes were used throughout, and since age is significant in the development of neurotoxic effects all the birds used were at least 18 months old (Barnes and Denz, 1953) . The agents were given intramuscularly as a 1% dilution in 10% ethanol saline (Austin and Davies, 1954) , within 0.5 hr. of preparation of the solution.
Where an agent was known to be unstable or insoluble in water the solution was made up in isopropanol.
Slight deviations from this procedure were made when the dose to be administered was greater than 10 mg./ kg. Under these circumstances the concentration of the agent was adjusted to keep the volume of the injected solution between 0.2 and 1.0 ml.
Many of the agents used were so lethal that each bird had to be protected by the intramuscular injection of 2-hydroxyiminomethyl-N-methylpyridinium methanesulphonate (P2S) 100 mg./kg. and of atropine sulphate 1 mg./kg. 10 min. before the injection of the agent. Preliminary experiments with dyflos showed that, whilst such treatment saved the lives of birds given many times a lethal dose, it had no effect upon either the incidence, the severity or the onset of neurotoxic effects. Despite the protective effect of P2S and atropine some compounds were so toxic that the dose levels necessary for adequate testing could only be given in 20% daily aliquots of the total.
Occasionally, for very specific reasons, P2S was not administered. In these instances the dose of atropine was increased and this is indicated either in the tables or the text.
In the chicken the interval between poisoning and the onset of paralysis is always between 9 and 14 days; all birds were therefore observed for a period of 21 days from the completion of the injections. The absence of bilateral leg weakness and ataxia at the end of this period was taken as a negative result and the compound was considered inactive. With a number of the compounds, particularly those which did not produce leg weakness or ataxia, the period of observation was longer. The onset of such signs in a shorter interval than 7 days was regarded as atypical and the test was repeated.
All the birds were killed either at the end of the observation period or when they developed unequivocal clinical signs. The sciatic nerves, spinal cord and cerebellum of many of these clinically positive birds were examined histologically.
RESULTS
The Acute Effects of Organophosphorus Com- 5/7 11 2 birds showed no signs i-C4H9-C2H5-2-9 2-9 2/6 6 4 birds died from acute effects. Dosing was spread over 7 days. The delay period was therefore difficult to assess always being noticeable 9 to 15 days after poisoning (Table II) . The Alkylphosphonofluoridates.-The toxicity of the alkylphosphonofluoridates was so great that demonstration of their neurotoxicity was very difficult. Treatment with P2S and atropine was consistently effective in protecting birds against the lethal effects of 0.5 mg./kg., but not against higher doses. These were therefore given in divided doses, usually 20% daily aliquots of the total dose to be tested. Where this was done is indicated in Table III . Five compounds were examined at doses ranging from 0.5 to 15.0 mg./kg. All five were active between 1.0 and 5.0 mg. /kg. (Table III) .
The Phosphorofluoridothionates.-Diethyl phosphorofluoridothionate was examined in order to determine the significance of the oxygen atom directly attached to the phosphorus atom. It was neurotoxic at 5.0 mg. /kg., but the sample contained 10% of an impurity, which was probably the oxygen analogue.
Diethyl phosphorofluoridate was therefore re-tested under comparable conditions. It was non-neurotoxic at 0.5 mg./kg. and neurotoxic at 0.75 mg. /kg. Thus even if all the impurity present in the sample of diethyl phosphorofluoridothionate was the oxygen analogue it would not be sufficient to account for the neurotoxicity of the sulphur compound.
The Dialkylphosphinic Fluorides.-Four compounds of this type were tested. Their formulae are shown in Table I . In a preliminary experiment the di-n-propyl and the di-n-butyl analogues were examined, in the presence of P2S and atropine at maximum doses of 5.0 and 2.5 mg./ kg. respectively. Neither was neurotoxic. Since it was thought that the oxime might catalyse the breakdown of the agent, all four compounds were tested in the absence of the P2S, but the dose of atropine was increased to 10 mg./kg. Again the compounds produced no effect, although one bird given 5.0 mg. /kg. di-n-propylphosphinic fluoride exhibited atypical symptoms 27 days after poisoning.
The Dialkylpyrophosphonates.-Five dialkyl dialkylpyrophosphonates and ethyl pyrophosphate were examined. With the exception of ethyl pyrophosphate they were tested at doses varying from 1 to 10 mg./kg. Ethyl pyrophosphate was tested more vigorously, cumulative doses of up to 100 mg./kg. being administered over a period of a week. The period of observation was also prolonged and in some cases lasted for 56 days. None of these compounds produced neurotoxicity. It is possible that the maximum doses of 10 mg. / TABLE IV THE NEUROTOXICITY OF PHOSPHOROFLUORIDOTHIONATES Dose schedule as described in Table II. kg. were too low to define adequately a negative response. The intrinsic toxicity of these compounds, however, is so high that even with these comparatively small quantities the birds received many times the LD5O dose. Miscellaneous Compounds.-The formulae of nine miscellaneous compounds investigated are also shown in Table I . These are essentially "phosphorofluoridates " in which the fluorine has been replaced by other radicals. These were also non-neurotoxic, even though some were tested at 50 to 100 mg./kg., for example, diethyl phosphorocyanidate, diisopropyl phosphoramidate, di-ocresyl methyl phosphate and diethyl phosphorochloridate.
DISCUSSION
Thirty-six organophosphorus compounds have been examined for neurotoxicity. The various classes of compounds and the individual members of each were chosen with the object of assessing the importance which the individual groups, attached to the phosphorus atom, have in producing these effects. The results are summarized in Table V. All the phosphorofluoridates tested were neurotoxic, from the dimethyl to the di(l-methylbutyl) homologue, suggesting that the actual nature of the ester alkyl group is not critical; this is supported by the observation that dicyclohexyl phosphorofluoridate and the mixed alkyl ester, ethyl propyl phosphorofluoridate, also produce neurotoxicity.
At least one alkoxyl group seems to be necessary, for the alkylphosphonofluoridates are neurotoxic, whereas the dialkylphosphinic fluorides are not. The ester oxygen of the phosphorofluoridates may be replaced by an amino-group as in mipafox, but The significance of the fluorine atom suggests that it plays a direct role in the development of the biochemical lesion. This may result from its being carried by the compound as a whole to specific areas in the nervous system. At these sites ionic fluorine may be liberated by rupture of the P-F bond. This may occur by the action of cholinesterase, but this need not be the only mechanism involved. The need to deposit the fluorine at these specific sites determines the character of the rest of the molecule.
Substitution of the fluorine atom by a chlorine or bromine atom results in a very unstable molecule which almost certainly does not penetrate the central nervous system intact. This is borne out by the lack of toxicity of such compounds. Compounds like the dialkyl dialkylpyrophosphonates are more stable, and there is little doubt as judged by their acute toxic effects that they enter the central nervous system. An explanation for their lack of neurotoxicity must therefore be sought elsewhere. The hypothesis offered above is capable, however, of explaining the absence of neurotoxicity of these substances, for the rupture of the P-X bond in different compounds will result in the production in vivo of a variety of substances with markedly different properties. Thus the pyrophosphates would yield derivatives of orthophosphoric acid, and these do not possess properties similar to hydrofluoric acid.
Whilst this working hypothesis offers at least a partial explanation of the neurotoxicity of organophosphorus compounds of type I, it must not be forgotten that triaryl phosphates are similarly neurotoxic. This hypothesis, however, can be modified to cover such compounds, but its adaptation to these cases will be considered in a later communication.
The neurotoxic hazard which these substances constitute to man is a difficult problem to assess because of (a) known species differences in the response to organophosphorus compounds, and (b) the absence of any direct evidence that organophosphorus compounds other than tri-o-cresyl phosphate and mipafox are neurotoxic in humans. Both of these have been extensively examined in the chicken. The delay period, the clinical character of the condition and the distribution and nature of the histological lesions are all the same as those found with dyflos and the compounds which have, in this study, been reported active for the first time. It must therefore be assumed that all the organophosphorus compounds shown to be neurotoxic in chickens will, under appropriate conditions, produce neurotoxicity in man.
